0: AD is a prevalent disease that affects more than 26 million people globally, and is the most common neurodegenerative disease worldwide [ 7].
1: AChE inhibitors (AChEIs) have medical applications and are particularly important for the symptomatic treatment of Alzheimers disease [ 8].
2: The butyrylcholinesterase enzyme (BChE) is synthesized in the liver and its main function is to hydrolyze hydrophobic and hydrophilic carboxylic or phosphoric acid ester containing compounds.
3: Its toxicological and pharmacological importance becomes clear when an individual is exposured to poisonous compounds targeting the acetylcholine binding sites.
4: When there is a hepatic alteration, its concentration decreases in direct relation with the altered hepatocytes [ 9, 10].
